The Use of Radioligand Treatments in Metastatic Castration-Resistant Prostate Cancer – Matthew Abramowitz
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Matthew Abramowitz, MD, Associate Professor, Department of Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL Rana McKay, MD , Medical Oncologist, Associate…